IP Library Granted Patent US 12,063,929
Granted Patent B2
US 12,063,929 · App. 17/309,256 · Granted Aug 20, 2024

3′-alkynyl abscisic acid derivatives as ABA antagonists

Inventors: Suzanne R. Abrams (Saskatoon, CA); Leon Lai (Saskatoon, CA); Naveen Diddi (Saskatoon, CA)
Assignee: UNIVERSITY OF SASKATCHEWAN
A01N37/42A01P21/00C07C59/90C07C69/738
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,063,929
App. No.
17/309,256
Granted
Aug 20, 2024
Kind
B2
Abstract

The present application relates to novel 3′-unsaturated abscisic acid (ABA) derivatives of Formula (I) as ABA antagonists. For example, the present application relates to methods of using compounds of Formula (I) for reducing adverse effects of an ABA response in plants such as lentil and promoting germination. (I) The present application also relates to methods of using 3′-phenyl abscisic acid (ABA) derivatives of Formula (II) as ABA antagonists, for example, for reducing adverse effects of an ABA response in plants such as lentil and promoting germination. (II)

Claims (48)

1. A compound of Formula (I) or an enantiomer, salt, and/or solvate thereof:

wherein

L is —C═C— or —C≡C—;

R 1 is C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, (CH 2 ) 0-2 C 3-10 cycloalkyl, (CH 2 ) 0-2 aryl, (CH 2 ) 0-2 heterocycloalkyl, or (CH 2 ) 0-2 heteroaryl, each being optionally substituted with one or more of halo, CN, OH, NH 2 , C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, NH(C 1-6 alkyl), N(C 1-6 alkyl)(C 1-6 alkyl), OC 1-6 alkyl, OC 2-6 alkenyl, OC 2-6 alkynyl, (CH 2 ) 0-2 C 3-10 cycloalkyl, (CH 2 ) 0-2 aryl, (CH 2 ) 0-2 heterocycloalkyl, (CH 2 ) 0-2 heteroaryl, O(CH 2 ) 0-2 C 3-10 cycloalkyl, O(CH 2 ) 0-2 aryl, O(CH 2 ) 0-2 heterocycloalkyl, or O(CH 2 ) 0-2 heteroaryl, the latter 16 groups being optionally substituted with one or more of halo, OH, NH 2 , C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, OC 1-16 alkyl, OC 2-6 alkenyl, or OC 2-6 alkynyl; and

R 2 is H, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, cycloalkyl, aryl, heterocycloalkyl or heteroaryl, the latter 7 groups being optionally substituted with one or more of halo, OH, NH 2 , C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, OC 1-16 alkyl, OC 2-6 alkenyl, or OC 2-6 alkynyl,

wherein each alkyl, alkenyl, and alkynyl are optionally fluorosubstituted.

2. The compound of claim 1 , wherein R 1 is (CH 2 ) 0-2 aryl optionally substituted with one or more of halo, CN, OH, NH 2 , C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, NH(C 1-6 alkyl), N(C 1-6 alkyl)(C 1-6 alkyl), OC 1-6 alkyl, OC 2-6 alkenyl, OC 2-6 alkynyl, (CH 2 ) 0-2 C 3-10 cycloalkyl, (CH 2 ) 0-2 aryl, (CH 2 ) 0-2 heterocycloalkyl, (CH 2 ) 0-2 heteroaryl, O(CH 2 ) 0-2 C 3-10 cycloalkyl, O(CH 2 ) 0-2 aryl, O(CH 2 ) 0-2 heterocycloalkyl or O(CH 2 ) 0-2 heteroaryl, the latter 16 groups being optionally substituted with one or more of halo, OH, NH 2 , C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, OC 1-16 alkyl, OC 2-6 alkenyl, or OC 2-6 alkynyl, wherein each alkyl, alkenyl, and alkynyl are optionally fluorosubstituted.

3. The compound of claim 1 , wherein R 1 is aryl optionally substituted with one or more of OH, halo, C 1-10 alkyl, OC 1-6 alkyl, or O(CH 2 ) 0-2 aryl, wherein each alkyl, alkenyl, and alkynyl are optionally fluorosubstituted.

4. The compound of claim 1 , wherein R 1 is C 1-10 alkyl optionally substituted with one or more of halo, CN, OH, NH 2 , C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, NH(C 1-6 alkyl), N(C 1-6 alkyl)(C 1-6 alkyl), OC 1-6 alkyl, OC 2-6 alkenyl, OC 2-6 alkynyl, (CH 2 ) 0-2 C 3-10 cycloalkyl, (CH 2 ) 0-2 aryl, (CH 2 ) 0-2 heterocycloalkyl, (CH 2 ) 0-2 heteroaryl, O(CH 2 ) 0-2 C 3-10 cycloalkyl, O(CH 2 ) 0-2 aryl, O(CH 2 ) 0-2 heterocycloalkyl, or O(CH 2 ) 0-2 heteroaryl, the latter 16 groups being optionally substituted with one or more of halo, OH, NH 2 , C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, OC 1-16 alkyl, OC 2-6 alkenyl, or OC 2-6 alkynyl, wherein each alkyl, alkenyl, and alkynyl are optionally fluorosubstituted.

5. The compound of claim 4 , wherein R 1 is C 1-10 alkyl optionally substituted with one or more of halo, CN, OH, NH 2 , C 1-10 alkyl, C 2-10 alkenyl, or C 2-10 alkynyl, wherein each alkyl, alkenyl, and alkynyl are optionally fluorosubstituted.

6. The compound of claim 1 , wherein R 1 is C 2-10 alkenyl optionally substituted with one or more of halo, CN, OH, NH 2 , C 1-10 alkyl, C 2-10 alkenyl, or C 2-10 alkynyl, wherein each alkyl, alkenyl, and alkynyl are optionally fluorosubstituted.

7. The compound of claim 1 , wherein R 1 is (CH 2 ) 0-2 C 3-10 cycloalkyl optionally substituted with one or more of halo, CN, OH, NH 2 , C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, NH(C 1-6 alkyl), N(C 1-6 alkyl)(C 1-6 alkyl), OC 1-6 alkyl, OC 2-6 alkenyl, OC 2-6 alkynyl, (CH 2 ) 0-2 C 3-10 cycloalkyl, (CH 2 ) 0-2 aryl, (CH 2 ) 0-2 heterocycloalkyl, (CH 2 ) 0-2 heteroaryl, O(CH 2 ) 0-2 C 3-10 cycloalkyl, O(CH 2 ) 0-2 aryl, O(CH 2 ) 0-2 heterocycloalkyl, or O(CH 2 ) 0-2 heteroaryl, the latter 16 groups being optionally substituted with one or more of halo, OH, NH 2 , C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, OC 1-16 alkyl, OC 2-6 alkenyl, or OC 2-6 alkynyl, wherein each alkyl, alkenyl, and alkynyl are optionally fluorosubstituted.

8. The compound of claim 7 , wherein R 1 is C 3-10 cycloalkyl optionally substituted with one or more of halo, CN, OH, NH 2 , C 1-10 alkyl, C 2-10 alkenyl, or C 2-10 alkynyl, wherein each alkyl, alkenyl, and alkynyl are optionally fluorosubstituted.

9. The compound of claim 1 , wherein R 2 is H or C 1-10 alkyl.

10. The compound of claim 1 , wherein L is —C═C—.

11. The compound of claim 1 , wherein L is —C≡C—.

12. The compound of Formula (I) or a salt, and/or solvate thereof of claim 1 , wherein the compound has the following stereochemistry:

13. The compound of Formula (I) of claim 1 selected from the compounds listed below:

Compound I.D

Structures

1018

1019

1021

1022

1023

1024

1025

1059

1063

1090

1091

1100

or a salt, and/or solvate thereof.

14. A method for reducing adverse effects of an ABA response in a plant in need thereof comprising administering an effective amount of one or more compounds of claim 1 or salt and/or solvate thereof to the plant.

15. The method of claim 14 , wherein the adverse effects of an ABA response include delayed or inhibited seed germination and/or plant dessication, over-ripening of fruit, slow bud breaking and/or slow plant growth.

16. The method of claim 14 , wherein the adverse effects of an ABA response occur under stress conditions.

17. A method for reducing adverse effects of an ABA response in a plant in need thereof comprising administering an effective amount of one or more compounds of the Formula (II) or an enantiomer, salt, and/or solvate thereof, to the plant,

wherein:

n is 0, 1, 2 or 3;

R 3 is selected from OH, halo, C 1-10 alkyl, OC 1-6 alkyl, and O(CH 2 ) 0-2 aryl, the latter 3 groups being optionally substituted with one or more of halo, OH, NH 2 , C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, OC 1-16 alkyl, OC 2-6 alkenyl, or OC 2-6 alkynyl; and

R 4 is selected from H or C 1-10 alkyl,

wherein each alkyl, alkenyl, and alkynyl is optionally fluorosubstituted, and

provided the compound of Formula II is not

18. The method of claim 17 , wherein the effective amount of the compound is about 0.1 μM to about 600 μM.

19. The method of claim 14 , wherein the plant is canola, lentil, chickpea, Arabidopsis , faba bean, soybean, corn, rice, wheat, rye, barley, or fruit plant.

20. The method of claim 14 , wherein one or more compounds of claim 1 or salt and/or solvate thereof is administered in combination with other known agents useful for regulating plant development.

21. The method of claim 17 , wherein the effective amount of the compound is about 1 μM to about 500 μM.

22. The method of claim 17 , wherein the effective amount of the compound is about 5 μM to about 250 μM.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2022
From: ABRAMS, SUZANNE R.; LAI, LEON; DIDDI, NAVEEN
To: UNIVERSITY OF SASKATCHEWAN
Reel/Frame 059157/0783 →
Continuity (2)
Provisional Application 62769331 · Nov 19, 2018
Related Publication 20210392885A1 · Dec 23, 2021